Dr. Steven Brooks, MBA ’11

Senior VP for Medical Science and Regulatory Affairs
Vita Therapeutics

Doctor Steven Brooks, MBA ’11  Senior VP for Medical Science and Regulatory Affairs Vita Therapeutics

Dr. Brooks joined Vita Therapeutics as SVP of medical science and regulatory affairs in January 2021. He is a multi-faceted health care consultant, publisher, and clinical trialist. Interests include regulatory strategy, scientific and medical due diligence, and medical technology commercialization.  An Interventional Cardiologist who worked six years as a Medical Officer for the FDA in the Office of Device Evaluation (ODE). He is currently a principal in Brooks Medtech, LLC, a Senior Analyst with Popper and Company, and an Expert Consultant with NDA Partners.  In these roles Steve is active in developing thought leadership, content and consultation on multiple interconnected strategic areas.  By leveraging a large network of contacts in academia, government, including the FDA and CMS, and industry, nuanced guidance is developed for diverse client needs.  Steve holds industry and board positions with medical technology companies, and continues to teach and mentor at Johns Hopkins University and University of Maryland.